DE602004015966D1 - Lipidregulierendes mittel und dessen verwendung - Google Patents

Lipidregulierendes mittel und dessen verwendung

Info

Publication number
DE602004015966D1
DE602004015966D1 DE602004015966T DE602004015966T DE602004015966D1 DE 602004015966 D1 DE602004015966 D1 DE 602004015966D1 DE 602004015966 T DE602004015966 T DE 602004015966T DE 602004015966 T DE602004015966 T DE 602004015966T DE 602004015966 D1 DE602004015966 D1 DE 602004015966D1
Authority
DE
Germany
Prior art keywords
lipid regulating
regulating medium
lipid
medium
regulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015966T
Other languages
German (de)
English (en)
Inventor
Kazuyuki Oku
Michio Kubota
Shigeharu Fukuda
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of DE602004015966D1 publication Critical patent/DE602004015966D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004015966T 2003-04-03 2004-03-24 Lipidregulierendes mittel und dessen verwendung Expired - Lifetime DE602004015966D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003100408 2003-04-03
PCT/JP2004/004079 WO2004089964A1 (ja) 2003-04-03 2004-03-24 脂質調節剤及びその用途

Publications (1)

Publication Number Publication Date
DE602004015966D1 true DE602004015966D1 (de) 2008-10-02

Family

ID=33156723

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015966T Expired - Lifetime DE602004015966D1 (de) 2003-04-03 2004-03-24 Lipidregulierendes mittel und dessen verwendung

Country Status (7)

Country Link
US (2) US20060276432A1 (enExample)
EP (1) EP1616873B1 (enExample)
JP (1) JP4893981B2 (enExample)
CN (1) CN100540559C (enExample)
DE (1) DE602004015966D1 (enExample)
TW (1) TW200501964A (enExample)
WO (1) WO2004089964A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007171A1 (ja) * 2003-07-18 2005-01-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ミネラル吸収促進剤及びその用途
GB2445891B (en) * 2005-09-22 2010-11-10 Hayashibara Biochem Lab Immunomodulating agent in gut
JP2007267618A (ja) * 2006-03-30 2007-10-18 Mukogawa Gakuin ケーキ
JP2010053122A (ja) * 2008-07-31 2010-03-11 Hayashibara Biochem Lab Inc 脂質合成阻害剤
EP2391371B1 (en) 2009-01-27 2014-11-26 World Force Technologies, LLC A high molecular weight polysaccharide that binds and inhibits virus
JP2010215544A (ja) * 2009-03-13 2010-09-30 Hiroshima Univ 血管新生抑制剤、これを含有する医薬、血管新生抑制剤を産生させる整腸剤、並びに、血管新生抑制剤の投与方法
JP2014185088A (ja) * 2013-03-22 2014-10-02 Sunstar Inc 経口組成物、脂肪細胞分化抑制剤および飲食品
US10925854B2 (en) * 2015-11-19 2021-02-23 Sinew Pharma Inc. Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders
JP7136765B2 (ja) * 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
FR3087339A1 (fr) * 2018-10-22 2020-04-24 Nexira Composition pour traiter le surpoids et/ou l'obesite
ES3021837T3 (en) 2019-10-04 2025-05-27 Nagase Viita Co Ltd Sugar composition containing cyclic tetrasaccharide, use thereof, and production method therefor
JP7741642B2 (ja) * 2021-03-31 2025-09-18 ナガセヴィータ株式会社 アルコール飲料、及び、アルコール飲料の苦味を抑制する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6094912A (ja) * 1983-10-28 1985-05-28 Masashige Suzuki 体内中性脂肪低減剤
JPH07115934A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤
US5786196A (en) * 1995-06-12 1998-07-28 The United States Of America As Represented By The Secretary Of Agriculture Bacteria and enzymes for production of alternan fragments
US7192746B2 (en) * 2000-05-22 2007-03-20 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo α-Isomaltosyltransferase, process for producing the same and use thereof
TWI312369B (en) 2000-08-01 2009-07-21 Hayashibara Biochem Lab A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof
US7223570B2 (en) 2001-03-09 2007-05-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Branched cyclic tetrasaccharide, process for producing the same, and use
JP2003160595A (ja) * 2001-11-20 2003-06-03 Hayashibara Biochem Lab Inc 糖誘導体

Also Published As

Publication number Publication date
US8940715B2 (en) 2015-01-27
CN1768071A (zh) 2006-05-03
JPWO2004089964A1 (ja) 2006-07-06
TW200501964A (en) 2005-01-16
EP1616873B1 (en) 2008-08-20
CN100540559C (zh) 2009-09-16
EP1616873A4 (en) 2007-01-10
TWI330085B (enExample) 2010-09-11
US20060276432A1 (en) 2006-12-07
JP4893981B2 (ja) 2012-03-07
WO2004089964A1 (ja) 2004-10-21
WO2004089964A8 (ja) 2004-12-29
EP1616873A1 (en) 2006-01-18
US20080214499A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
ATE391718T1 (de) Phenylacetamide und ihre verwendung als glukokinase-modulatoren
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
DE60302378D1 (de) Optisches Aufzeichnungsmedium und zugehöriges Aufzeichnungsverfahren
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE602004028934D1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
ATE529420T1 (de) 3-ä(2-ää4-hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester-methansulfonat-hemihydrat und dessen verwendung als arzneimittel
DE602004026860D1 (de) Objektidentifikationsmedium und identifikationsverfahren
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ATE455629T1 (de) Rasierer und kassetten
ATE542648T1 (de) Rasierer und kassetten
EP1746902A4 (en) MULTI-LECTIN AFFINITY CHROMATOGRAPHY AND USES THEREOF
DE602004029844D1 (de) Pigmentdispersion und deren Verwendung
ATE432701T1 (de) Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren
DE602004015966D1 (de) Lipidregulierendes mittel und dessen verwendung
DE602004021384D1 (de) Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren
DE60322551D1 (de) 2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren
DE602004028700D1 (de) Kosmetische Zusammensetzungen und deren Verwendung
DE60336025D1 (de) Kollimator und bestrahler
DE60230162D1 (de) Polymerisate und ihre verwendung
ATE396994T1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE602004018678D1 (de) Film und den film verwendendes magnetaufzeichnungsmedium
DE602004010815D1 (de) Fluidproduktabgabekopf und dessen verwendung
DK1736159T3 (da) Hudplejemiddel
ATE484503T1 (de) 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
DE50300769D1 (de) Erdalkalialuminosilicatglas und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition